CHF in the Elderly Using ACEIs Appropriately

Healthcare providers are still prescribing angiotensin-converting enzyme (ACE) inhibitors to the elderly at lower than recommended dosages despite its well known benefits, including alleviating symptoms, improving clinical status, and significantly decreasing the risk of disease progression and deat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Nurse practitioner 2004-07, Vol.29 (7), p.46-52
Hauptverfasser:	Naylor, Lisa, Howe, Linda, Eggert, Julie, Heifferon, Barbara
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Angiotensin-Converting Enzyme Inhibitors - therapeutic use Clinical trials Cough - chemically induced Dose-Response Relationship, Drug Drug dosages Drug Monitoring - methods Drug therapy Guidelines as Topic Heart failure Heart Failure - drug therapy Humans Hyperkalemia - chemically induced Hypotension - chemically induced Older people Patient Education as Topic - methods Renal Insufficiency - chemically induced Side effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Healthcare providers are still prescribing angiotensin-converting enzyme (ACE) inhibitors to the elderly at lower than recommended dosages despite its well known benefits, including alleviating symptoms, improving clinical status, and significantly decreasing the risk of disease progression and death in patients with congestive heart failure (CHF). The under-prescription of ACE inhibitors to patients with advanced age with CHF is investigated.
ISSN:	0361-1817 1538-8662
DOI:	10.1097/00006205-200407000-00008